Viral glycoprotein (monomer)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d61/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d61/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d60/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d60/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d5f/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d5f/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d5e/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d5e/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d5d/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d5d/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d5c/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d5c/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d5b/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d5b/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d5a/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d5a/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d59/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d59/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d58/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d58/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d57/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d57/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d56/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d56/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d55/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d55/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d54/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d54/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d53/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d53/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d52/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d52/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d51/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d51/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d50/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d50/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d4f/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d4f/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d4e/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d4e/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d4d/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d4d/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d4c/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d4c/5e7e56c8e0bbaa0028b16d4a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e5711e0bbaa0028b16d4b/5e7e56c8e0bbaa0028b16d4a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e5711e0bbaa0028b16d4b/5e7e56c8e0bbaa0028b16d4a.png"}]